MainboardNSELISTED

Annu Projects IPO

₹94 – ₹94 · Issue Size ₹175 Cr

IPO Overview

StatusListed
Price Band₹94 – ₹94
Issue Size₹175 Cr
Lot Size151 shares
Min Investment₹14,949
Face Value₹10
Issue Structure
Fresh Issue₹175 Cr
Offer for Sale
Total Size₹175 Cr

IPO Timeline

Open Date25 Aug 2026
Close Date28 Aug 2026
Allotment31 Aug 2026
Refund1 Sept 2026
Credit to Demat1 Sept 2026
Listing Date2 Sept 2026

Listing Performance

Issue Price₹94 – ₹94
Listing Price
Listing Gain

Strengths & Weaknesses

Strengths

  • Established expertise in engineering, procurement and commissioning projects with special focus on underground and
  • Leveraging our expertise of over two decades, we have developed project execution proficiency and have diversified

Management & Promoters

S
Sanjay Kumar SarrafChairman and Managing Director
F
Foreign CompaniesIndependent Director
K
Krishna RanjanWhole-Time Director
I
Indian CompaniesIndependent Director
N
Nalini Shastri VanjaniIndependent Director
F
Fareed AhmedIndependent Director
R
Radhakrishnan NagarajanIndependent Director
I
Interest Of DirectorsDirector
I
Interest OfDirector

Shareholding Pattern

Pre-IPO
Category%
Employees5%
Promoters87.64%
Employees6%
Promoters89.11%

Peer Comparison

CompanyP/EEPS
Annu Projects IPO
Telephone: +91.0x
Telephone: +91.0x
Dated June27.0x
Please read Section of the Companies Act32.0x
Corporate Identity Number: UDLPLC;

Pre-IPO Financials

PeriodRevenue (Cr)PAT (Cr)Net Worth (Cr)Total Assets (Cr)
2025₹31 Cr₹31 Cr₹1,898.96 Cr
2013₹2,023 Cr₹2,023 Cr₹1,613.39 Cr
2018₹31 Cr₹31 Cr₹1,474.76 Cr
2019₹2,022 Cr₹2,022 Cr₹1,420.34 Cr

About

Q-Line Biotech Ltd. (QBL) is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributor/s majorly to diagnostic service providers, hospitals and medica

Industry Overview

Key Regulations and Policies in India", "History and Certain Corporate Matters", "Summary of Financial Information", "Financial Indebtedness", "Restated Consolidated Financial Information", "Outstanding Litigation and Other Material Developments, "Other Regulatory and Statutory Disclosures", and "Main Provisions of the Articles of Association", beginning on pages 114, 126, 136, 139, 256, 262, 81, 390, 290, 392, 400 and 444, respectively, will have the meaning ascribed to such terms in those respective sections. General Terms Term Description "our Company" or "the Company" Annu Projects Lim

ExchangeNSE
Issue Typemainboard
Face Value10 per share

Documents

rupiya.io is for research and education only. IPO data is sourced from public disclosures (DRHP/RHP). Not investment advice. Validate with SEBI-regulated disclosures before acting.